Table 3.
KEGG ID | Pathway description | Plasma | EV | Depleted |
---|---|---|---|---|
hsa04510 | Focal adhesion | 5.81E−15 | 6.35E−13 | 7.79E−04 |
hsa04012 | ErbB signalling pathway | 3.44E−12 | 1.24E−13 | 3.49E−03 |
hsa04520 | Adherens junction | 1.12E−11 | 1.37E−13 | 1.07E−03 |
hsa04110 | Cell cycle | 2.05E−11 | 2.53E−11 | 2.25E−02 |
hsa04917 | Prolactin signalling pathway | 7.10E−11 | 2.53E−09 | 2.22E−02 |
hsa04151 | PI3K‐Akt signalling pathway | 1.01E−10 | 2.57E−10 | 7.82E−04 |
hsa04144 | Endocytosis | 4.92E−10 | 2.41E−09 | 7.03E−05 |
hsa04540 | Gap junction | 3.70E−09 | 1.34E−05 | |
hsa04350 | TGF‐beta signalling pathway | 5.50E−09 | 1.56E−08 | 1.79E−05 |
hsa04666 | Fc gamma R‐mediated phagocytosis | 1.13E−07 | 1.56E−08 | 5.99E−04 |
hsa04071 | Sphingolipid signalling pathway | 1.49E−06 | 4.17E−06 | 1.56E−03 |
hsa04664 | Fc epsilon RI signalling pathway | 2.60E−06 | 2.07E−05 | |
hsa04370 | VEGF signalling pathway | 1.21E−04 | 2.13E−05 | |
hsa04010 | MAPK signalling pathway | 2.27E−04 | 3.80E−04 | 6.45E−02 |
hsa04530 | Tight junction | 9.45E−04 | 3.28E−04 | 3.86E−03 |
hsa04512 | ECM‐receptor interaction | 2.84E−03 | ||
hsa04068 | FoxO signalling pathway | 5.16E−08 | 4.43E−09 | 1.11E−02 |
hsa04152 | AMPK signalling pathway | 2.19E−03 | 5.64E−06 | 5.88E−02 |
hsa04914 | Progesterone‐mediated oocyte maturation | 6.89E−03 | 1.37E−03 |